Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-24, Stock:JNJ, The news for the past five days is as follows:
2020-09-17: NEWS1: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS2: New York Files Charges Against Johnson & Johnson Over Opioid Marketing.NEWS3: Economic recovery won’t come until we get Americans to feel safe: Ric Edelman.NEWS4: Infectious Diseases Physician on COVID-19 vaccine outlook: 'It’s less about what’s the exact date, but making sure it’s effective'.NEWS5: Johnson & Johnson stock underperforms Thursday when compared to competitors.NEWS6: FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show.NEWS7: Johnson & Johnson Faces New York State Insurance Fraud Action Linked to Opioid Crisis.NEWS8: Race for a COVID-19 vaccine continues, here's what you need to know.NEWS9: New York charges Johnson & Johnson with insurance fraud over opioid claims.
2020-09-18: NEWS1: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS2: First Psychedelic Drug Stock Hits $1 Billion In Debut After Upsized IPO.NEWS3: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS4: Three-quarters of Americans are worried about the vaccine rush: Pew.NEWS5: The First Psychedelic Drug Stock Jumps In Debut After Upsized IPO.NEWS6: Dow Jones Extends Losses As Apple Drops; Nasdaq Falls Deeper In The Red.NEWS7: EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.?.NEWS8: Price Over Earnings Overview: Johnson & Johnson.NEWS9: Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit.NEWS10: Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best'.NEWS11: These 3 Dividend Aristocrats Will Shield You From Another Market Crash.NEWS12: How Much Of Johnson & Johnson (NYSE:JNJ) Do Institutions Own?.NEWS13: 3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other.NEWS14: 20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening.NEWS15: Johnson & Johnson Downplayed Opioid Drugs' Side Effects, New York Unveils Charges.
2020-09-21: NEWS1: Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail.NEWS2: Johnson & Johnson stock falls Monday, underperforms market.NEWS3: Instead of Going Public, Cancer-Testing Spinoff Grail Is Returning to Illumina.NEWS4: Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain..NEWS5: Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later.NEWS6: Why Legend Biotech Stock Is Sinking Today.
2020-09-22: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Johnson & Johnson stock underperforms Tuesday when compared to competitors.
2020-09-23: NEWS1: The Covid-19 Vaccine Candidates That Are Now in Phase 3 Trials.NEWS2: Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial.NEWS3: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS4: Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine.NEWS5: California Will Ban Sales of Gas-Powered Vehicles Starting in 2035.NEWS6: Dow Drops 400 Points as Fed Warns More Stimulus Is Needed, Tech Tumbles.NEWS7: Cramer Reacts To Johnson & Johnson's Coronavirus Vaccine Update: 'Not A Hype Company'.NEWS8: Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles.NEWS9: Dow Jones Red Despite Big Nike Rally; Nasdaq Drops As Tech Stocks Sell Off.NEWS10: Stocks Tumble as Recovery Worries Add to Volatility, Tesla Slides.NEWS11: EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source.NEWS12: US STOCKS-Wall Street retreats as business activity slows.NEWS13: Why Vaxart Stock Is Retreating Today.NEWS14: The Dow Is Struggling, and Tesla Stock Slumps.NEWS15: Justice Department Seeks to Limit Protections for Internet Companies.NEWS16: FDA commissioner: It's up to drug makers developing vaccines to seek approval or EUA.NEWS17: Fauci predicts U.S. will know if COVID-19 vaccines are effective by &quot;November or December&quot;.NEWS18: Stocks Waver as Recovery Worries Add to Volatility.NEWS19: J&J Launches Trial of Single-Dose Covid Vaccine. Results Could Come Quicker Than You Think..NEWS20: Nike, Johnson & Johnson share gains lead the way, but Dow flat.NEWS21: House Passes Spending Bill to Keep Government Funded Through Dec. 11.NEWS22: US STOCKS-S&P 500, Nasdaq retreat as business activity dips.NEWS23: Tesla's Battery Day Fizzles, J&J's Phase 3 Sizzles.NEWS24: Dow Jones Today Jumps, Nasdaq Dips As Nike Rallies; J&J Vaccine Enters Phase 3.NEWS25: P/E Ratio Overview: Johnson & Johnson.NEWS26: Johnson & Johnson Launches Phase 3 Coronavirus Vaccine Trial, Shares Jump.NEWS27: Nike, Boeing share gains contribute to Dow's 135-point climb.NEWS28: Economic Data Deluge.NEWS29: Return On Capital Employed Overview: Johnson & Johnson.NEWS30: Dow Trades Higher as Nike Surges on Big Earnings Beat.NEWS31: Dow rises over 100 points as stocks continue rebound from selloff.NEWS32: Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021.NEWS33: Dow Jones Today Jumps, Futures Mixed As Nike Rallies; J&J Vaccine Enters Phase 3.NEWS34: Johnson & Johnson Stock Is Jumping, General Mills Is Gaining, and the Dow Is Joining the Party.NEWS35: Johnson & Johnson's stock rallies after Phase 3 trial launched for COVID-19 vaccine candidate.NEWS36: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate.NEWS37: J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers.NEWS38: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate.

Answer: Rise